249 related articles for article (PubMed ID: 18779865)
1. Cthrc1 is a positive regulator of osteoblastic bone formation.
Kimura H; Kwan KM; Zhang Z; Deng JM; Darnay BG; Behringer RR; Nakamura T; de Crombrugghe B; Akiyama H
PLoS One; 2008 Sep; 3(9):e3174. PubMed ID: 18779865
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of osteoclast differentiation and collagen antibody-induced arthritis by CTHRC1.
Jin YR; Stohn JP; Wang Q; Nagano K; Baron R; Bouxsein ML; Rosen CJ; Adarichev VA; Lindner V
Bone; 2017 Apr; 97():153-167. PubMed ID: 28115279
[TBL] [Abstract][Full Text] [Related]
3. WAIF1 Is a Cell-Surface CTHRC1 Binding Protein Coupling Bone Resorption and Formation.
Matsuoka K; Kohara Y; Naoe Y; Watanabe A; Ito M; Ikeda K; Takeshita S
J Bone Miner Res; 2018 Aug; 33(8):1500-1512. PubMed ID: 29624737
[TBL] [Abstract][Full Text] [Related]
4. Osteoclast-secreted CTHRC1 in the coupling of bone resorption to formation.
Takeshita S; Fumoto T; Matsuoka K; Park KA; Aburatani H; Kato S; Ito M; Ikeda K
J Clin Invest; 2013 Sep; 123(9):3914-24. PubMed ID: 23908115
[TBL] [Abstract][Full Text] [Related]
5. Effect of osteoblast-targeted expression of bcl-2 in bone: differential response in male and female mice.
Pantschenko AG; Zhang W; Nahounou M; McCarthy MB; Stover ML; Lichtler AC; Clark SH; Gronowicz GA
J Bone Miner Res; 2005 Aug; 20(8):1414-29. PubMed ID: 16007339
[TBL] [Abstract][Full Text] [Related]
6. Deficiency in the phosphatase PHLPP1 suppresses osteoclast-mediated bone resorption and enhances bone formation in mice.
Mattson AM; Begun DL; Molstad DHH; Meyer MA; Oursler MJ; Westendorf JJ; Bradley EW
J Biol Chem; 2019 Aug; 294(31):11772-11784. PubMed ID: 31189651
[TBL] [Abstract][Full Text] [Related]
7. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of BCLXL in Osteoblasts Inhibits Osteoblast Apoptosis and Increases Bone Volume and Strength.
Moriishi T; Fukuyama R; Miyazaki T; Furuichi T; Ito M; Komori T
J Bone Miner Res; 2016 Jul; 31(7):1366-80. PubMed ID: 26852895
[TBL] [Abstract][Full Text] [Related]
9. Osteoblastic responses to TGF-beta during bone remodeling.
Erlebacher A; Filvaroff EH; Ye JQ; Derynck R
Mol Biol Cell; 1998 Jul; 9(7):1903-18. PubMed ID: 9658179
[TBL] [Abstract][Full Text] [Related]
10. In vivo inhibition of osteoblastic metalloproteinases leads to increased trabecular bone mass.
Geoffroy V; Marty-Morieux C; Le Goupil N; Clement-Lacroix P; Terraz C; Frain M; Roux S; Rossert J; de Vernejoul MC
J Bone Miner Res; 2004 May; 19(5):811-22. PubMed ID: 15068505
[TBL] [Abstract][Full Text] [Related]
11. Transgenic overexpression of tartrate-resistant acid phosphatase is associated with induction of osteoblast gene expression and increased cortical bone mineral content and density.
Gradin P; Hollberg K; Cassady AI; Lång P; Andersson G
Cells Tissues Organs; 2012; 196(1):68-81. PubMed ID: 22248481
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of Fam20C in osteoblast in vivo leads to increased cortical bone formation and osteoclastic bone resorption.
Hirose K; Ishimoto T; Usami Y; Sato S; Oya K; Nakano T; Komori T; Toyosawa S
Bone; 2020 Sep; 138():115414. PubMed ID: 32416287
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of TGF-beta receptor signaling in osteoblasts leads to decreased bone remodeling and increased trabecular bone mass.
Filvaroff E; Erlebacher A; Ye J; Gitelman SE; Lotz J; Heillman M; Derynck R
Development; 1999 Oct; 126(19):4267-79. PubMed ID: 10477295
[TBL] [Abstract][Full Text] [Related]
14. Wnt10b increases postnatal bone formation by enhancing osteoblast differentiation.
Bennett CN; Ouyang H; Ma YL; Zeng Q; Gerin I; Sousa KM; Lane TF; Krishnan V; Hankenson KD; MacDougald OA
J Bone Miner Res; 2007 Dec; 22(12):1924-32. PubMed ID: 17708715
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype.
Erlebacher A; Derynck R
J Cell Biol; 1996 Jan; 132(1-2):195-210. PubMed ID: 8567723
[TBL] [Abstract][Full Text] [Related]
16. Transgenic Expression of Osteoactivin/gpnmb Enhances Bone Formation In Vivo and Osteoprogenitor Differentiation Ex Vivo.
Frara N; Abdelmagid SM; Sondag GR; Moussa FM; Yingling VR; Owen TA; Popoff SN; Barbe MF; Safadi FF
J Cell Physiol; 2016 Jan; 231(1):72-83. PubMed ID: 25899717
[TBL] [Abstract][Full Text] [Related]
17. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
Okamoto M; Murai J; Yoshikawa H; Tsumaki N
J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
[TBL] [Abstract][Full Text] [Related]
18. Reduced trabecular bone mass and strength in mice overexpressing Gα11 protein in cells of the osteoblast lineage.
Dela Cruz A; Mattocks M; Sugamori KS; Grynpas MD; Mitchell J
Bone; 2014 Feb; 59():211-22. PubMed ID: 24308950
[TBL] [Abstract][Full Text] [Related]
19. Positive regulation of osteogenesis by bile acid through FXR.
Cho SW; An JH; Park H; Yang JY; Choi HJ; Kim SW; Park YJ; Kim SY; Yim M; Baek WY; Kim JE; Shin CS
J Bone Miner Res; 2013 Oct; 28(10):2109-21. PubMed ID: 23609136
[TBL] [Abstract][Full Text] [Related]
20. Osteoblast-targeted overexpression of PPARγ inhibited bone mass gain in male mice and accelerated ovariectomy-induced bone loss in female mice.
Cho SW; Yang JY; Her SJ; Choi HJ; Jung JY; Sun HJ; An JH; Cho HY; Kim SW; Park KS; Kim SY; Baek WY; Kim JE; Yim M; Shin CS
J Bone Miner Res; 2011 Aug; 26(8):1939-52. PubMed ID: 21351141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]